COR Q4 2024 Earnings — Cencora, Inc. Revenue & Financial Results | Market Cap Arena

CORCencora, Inc.

$69B

Q4 2024 Earnings

Healthcare Medical - Distribution

Income Statement

Revenue

$79.1B+14.7% YoY

Gross Profit

$2.2B2.7% margin

Operating Income

$673M0.9% margin

Net Income

$3M0.0% margin

EPS (Diluted)

$0.02

QoQ Revenue Growth

+6.5%

Cash Flow

Operating Cash Flow

$1.0B

Free Cash Flow

$818M

Stock-Based Comp.

$127M

Balance Sheet

Total Assets

$67.1B

Total Liabilities

$66.3B

Stockholders' Equity

$646M

Cash & Equivalents

$3.2B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$79.1B	$68.9B	+14.7%
Gross Profit	$2.2B	$1.9B	+13.5%
Operating Income	$673M	$513M	+31.2%
Net Income	$3M	$351M	-99.0%

Revenue Segments

Pharmaceutical Distribution

$130.3B88%

International Healthcare Solutions

$14.5B10%

Animal Health

$2.7B2%

Geographic Segments

U.S. Healthcare Solutions

$133.0B90%

International Healthcare Solutions

$14.5B10%